News

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...
Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...
Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...
A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...
With profound change in sight for the UK’s National Health Service (NHS), a new report indicates that a technology-driven ...
Carlsmed looks set to join the 2025 class of medtechs going public, though it has not yet set its share price range.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.
Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...
Elutia is a winner in the Innovation and Product Launches categories in the 2025 Medical Device Network Excellence Awards.
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...
ExoStat Medical has completed an intensive care unit (ICU) observational septic shock study of its MicroTREND System.